{"url_path":"/sec/inbs/8-k/2026-09-11/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-09-11","source_url":"https://www.sec.gov/Archives/edgar/data/1725430/0001493152-26-042411-index.html","accession_number":"0001493152-26-042411","cik":"0001725430","ticker":"INBS","issuer_name":"INTELLIGENT BIO SOLUTIONS INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1725430/0001493152-26-042411-index.html","primary_entity_key":"0001725430","primary_entity_name":"INTELLIGENT BIO SOLUTIONS INC."},"word_count":128,"has_tables":true,"body_markdown":"**Item\n8.01 Other Events.**\n\n \n\n*Shares\nOutstanding Update*\n\n** **\n\nAs\na result of (a) the exercise of previously disclosed outstanding prefunded warrants to purchase 285,000 shares of common stock, and (b)\nthe issuance of 4,333 shares of restricted common stock pursuant to the previously disclosed Investor Relations and Corporate Development\nAdvisory Agreement, dated February 29, 2024, the total number of outstanding shares of the Company’s common stock as of the close\nof business on September 10, 2026, is 3,316,803 shares.\n\n** **\n\n  \n\n \n\n****\n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDate:\nSeptember 11, 2026\n\n \n\n \n**INTELLIGENT\nBIO SOLUTIONS INC.**\n\n \n \n \n\n \nBy:\n\n*/s/\nSpiro Sakiris*\n\n \nName: \n\nSpiro\nSakiris\n\n \nTitle:\nChief\nFinancial Officer"}